Indo U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03) | Apply Online

Opportunity Summary:

The Indo-U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03) is a National Institutes of Health (NIH) funding opportunity designed to strengthen and expand collaborative vaccine research between institutions in the United States and India. It sits within a long history of formal U.S.-India scientific cooperation carried out under multiple bilateral frameworks, and it specifically builds on a Memorandum of Understanding signed on July 9, 1987 that established the Vaccine Action Program to promote joint vaccine-related research. The central aim of the VAP is practical and public-health focused: to support collaborative projects that can ultimately reduce the burden of infectious diseases that matter not only in India and the United States, but also across South Asia and globally.

This announcement solicits applications using the NIH Small Research Grant (R03) mechanism. In practical terms, that means the program is intended to fund smaller, targeted research efforts rather than large multi-year clinical programs. The R03 mechanism is typically used to support discrete projects that can generate early findings, pilot data, feasibility demonstrations, method development, or other foundational results that strengthen ongoing collaborations and help move vaccine concepts forward. The opportunity explicitly notes that it will provide U.S. dollar support for vaccine-related research conducted in India and/or the United States and is meant to augment current VAP activities, reinforcing the idea that these awards are often used to deepen or extend established lines of collaborative work.

The scientific scope is focused on vaccine-related research tied to major infectious disease priorities. Applications are specifically sought for research conducted through well-established collaborations with Indian investigators, and the targeted disease areas listed are dengue, influenza (including avian influenza), HIV/AIDS, and tuberculosis. The emphasis on well-established collaborations signals that the program is not only about funding individual projects, but also about strengthening durable research partnerships and shared scientific capacity across U.S. and Indian institutions in areas where vaccine development and evaluation can have major public health impact.

Eligibility is broad and includes a wide range of organization types. Eligible applicants include public and state-controlled institutions of higher education, private institutions of higher education, nonprofits (including those with and without 501(c)(3) status), state governments, small businesses, and for-profit organizations (including those that are not small businesses). The announcement also indicates that foreign institutions are eligible to apply and that eligible U.S. federal agencies may apply as well. This broad eligibility is consistent with the collaborative intent of the program, allowing participation from universities, research institutes, government entities, and industry partners where appropriate, as long as the application aligns with the program’s vaccine research goals and U.S.-India collaborative structure.

Administratively, the opportunity is listed as a discretionary grant in the health category and is associated with NIH. The funding opportunity number is PA-07-093, and the opportunity title is "Indo U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03)." It was posted on November 22, 2006, and uses multiple receipt dates rather than a single deadline, meaning applications were accepted on recurring submission cycles (with applicants directed to the full announcement for the exact receipt schedule). The listing shows no cost-sharing or matching requirement. The archived date is February 2, 2010, indicating the specific announcement is no longer active in that exact form, though the VAP concept and related NIH collaboration mechanisms may continue under newer solicitations.

For applicants needing the official details, the full announcement was provided through the NIH grants website at http://grants.nih.gov/grants/guide/pa-files/PA-07-093.html, and NIH’s Office of Extramural Research (OER) webmaster contact information is included for access or linking issues.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: HIV Infection Of The Central Nervous System (R01)

Previous opportunity: Dissemination and Implementation Research in Health (R01)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 07 093

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 07 093) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 07 093", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.